Michigan Alzheimer's Disease Research Center
Michigan Alzheimer's Disease Research Center
批准号:
10261108
负责人:
Henry L Paulson
金额:
$309.72万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-06-30
关键词:
AddressAffectAfrican AmericanAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease therapyAmericanAmyloid beta-ProteinAwardBiological MarkersCapsicumCenters of Research ExcellenceClinicalCognitionCollaborationsCommunitiesDementiaDevelopmentDiagnosisDiagnosticDisclosureDiseaseEducation and OutreachElderlyEnsureEnvironmentFoundationsFundingHealthHealth ProfessionalHeterogeneityHispanicsKnowledgeLatinoLeadLewy Body DementiaLightLinkLongitudinal cohortMentorsMichiganModificationMolecular ProfilingMulti-Institutional Clinical TrialNerve DegenerationNonpharmacologic TherapyParkinson DiseaseParticipantPeripheralPopulation ResearchProtein-Folding DiseaseResearchResearch SubjectsResearch SupportResourcesRiskScientistSiteStudentsTherapeuticTrainingUnited StatesUniversitiesVascular DementiaWorkaging demographybrain dysfunctioncontextual factorsdisorder riskeducation researchexperiencefrontotemporal lobar dementia-amyotrophic lateral sclerosisgene environment interactionhealth disparityimprovedinnovationmolecular imagingneuroimaging markernext generationnovelnovel diagnosticsnovel markernovel therapeutic interventionoutreachprogramsracial diversityrecruitsymposiumtraining opportunitytranslational neuroscience
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – OVERALL
Four years ago the Michigan ADRC (MADRC) was established as a new consortium linking the three major
research universities in Michigan: University of Michigan, Michigan State University, and Wayne State
University. Serving the entire state of Michigan, the new MADRC achieved its milestones in wide-ranging
activities and research that emphasized a central theme: to identify, understand and treat the myriad non-β-
amyloid contributions to brain dysfunction and degeneration in Alzheimer’s disease and related dementias
(ADRD). With continued NIA support, the MADRC proposes to maintain this central theme because it captures
the diverse expertise of our dementia scientists, sheds light on ADRD heterogeneity, and reflects the
experience of the racially diverse pool of research participants engaged in MADRC-sponsored studies. To
achieve its objectives, the MADRC has four major aims: 1) Catalyze and perform research of the highest
impact in ADRD; 2) Promote regional efforts to understand, diagnose and treat the full spectrum of dementias
through collaborative scientific and outreach efforts; 3) Provide training and research opportunities for health
care professionals, scientists, and students in ADRD through innovative educational and mentoring programs;
and 4) Collaborate with other ADRCs, the NACC, NCRAD, and other multi-center efforts to lead the field in
developing new diagnostic and therapeutic interventions for these devastating diseases. The integrated efforts
of seven Cores, including new Neuroimaging and Biomarker cores, will support a wide range of basic, clinical,
translational and health disparities research advancing the field toward: improved understanding of disease
mechanisms; more precise disease identification across the dementia spectrum; development of novel
biomarkers; increased knowledge of the basis for health disparities that disproportionately affect Black
Americans; development of non-pharmacological therapies; and the identification and modification of disease
risks. The Research Education Component (REC) will serve as the centerpiece of innovative training
opportunities spanning all the Cores, and a new Leaders Initiative will support and promote a diverse group of
next-generation leaders in dementia research. Benefitting from the outstanding resources of all three
universities and strong multi-institutional support, the MADRC is poised to make new discoveries, educate the
public, and train next-generation leaders as we seek to achieve the milestones set forth in the National
Alzheimer’s Project Act.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Michigan Alzheimer's Disease Research Center
-
批准号:10663286
-
项目类别:
-
资助金额:$357.44万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Core A: Administrative Core
-
批准号:10906471
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Core A: Administrative Core
-
批准号:10261109
-
项目类别:
-
资助金额:$48.45万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Michigan Alzheimer’s Disease Research Center-Supplement
-
批准号:10599387
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Research Education Component
-
批准号:10663310
-
项目类别:
-
资助金额:$9.7万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Michigan Alzheimer's Disease Research Center
-
批准号:10473806
-
项目类别:
-
资助金额:$307.59万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways
-
批准号:10396120
-
项目类别:
-
资助金额:$108.77万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Core A: Administrative Core
-
批准号:10663287
-
项目类别:
-
资助金额:$100.57万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways
-
批准号:10619544
-
项目类别:
-
资助金额:$108.77万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Research Education Component
-
批准号:10473841
-
项目类别:
-
资助金额:$9.7万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Core A: Administrative Core
-
批准号:10684514
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Core A: Administrative Core
-
批准号:10473807
-
项目类别:
-
资助金额:$50.11万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Michigan Alzheimer's Disease Research Center-Supplement
-
批准号:10768107
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Mechanisms of neurodegenerative diseases: intersections with ubiquitin pathways
-
批准号:10239410
-
项目类别:
-
资助金额:$103.83万
-
财政年份:2021
-
负责人:Henry L Paulson
-
依托单位:
Michigan Alzheimer's Disease Core Center
-
批准号:9980230
-
项目类别:
-
资助金额:$211.85万
-
财政年份:2016
-
负责人:Henry L Paulson
-
依托单位:
Michigan Alzheimer's Disease Core Center
-
批准号:9762762
-
项目类别:
-
资助金额:$171.87万
-
财政年份:2016
-
负责人:Henry L Paulson
-
依托单位:
Development of a Knock-in Mouse Model for Spinocerebellar Ataxia Type 3
-
批准号:8303313
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2011
-
负责人:Henry L Paulson
-
依托单位:
Development of a Knock-in Mouse Model for Spinocerebellar Ataxia Type 3
-
批准号:8188706
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2011
-
负责人:Henry L Paulson
-
依托单位:
AIM 2012 Conference
-
批准号:8443881
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:Henry L Paulson
-
依托单位:
AIM 2012 Conference
-
批准号:8256801
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2011
-
负责人:Henry L Paulson
-
依托单位:
海外基金